DE-111 Against Timolol Ophthalmic Solution 0.5%

Clinical trial NCT01342094 · COMPLETED

Trial details

NCT number: NCT01342094
Sponsor: Santen Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Open Angle Glaucoma Ocular Hypertension

Start date: 2011-05-01
Primary completion: 2012-09-01
Enrollment: 166

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.